首页 › 基金 › Marshall Financial Group, LLC › NVAX

Marshall Financial Group, LLC 对 NVAX 的持仓历史

NOVAVAX INC · 医疗保健

Marshall Financial Group, LLC 在 Q3 2026 的 13F 申报中披露持有 NVAX(NOVAVAX INC)404,016 股,市值约 US$4.4M,约占其申报组合的 0.62%,在其申报持仓中市值排名第 31 位。 Marshall Financial Group, LLC 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)404.02K 股
申报持仓市值$4.37M
组合权重0.62%
首次申报Q3 2026
最近变动新进
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

Marshall Financial Group, LLC 对 NVAX 的持仓演变

Marshall Financial Group, LLC 于 Q3 2026 首次披露 NVAX 持仓:404,016 股(约 US$4.4M)。

逐季持仓明细

季度股数金额变化
Q3 2026 404.02K $4.37M 新进

关于 NVAX 与 13F 数据

NVAX(NOVAVAX INC)属于医疗保健行业。我们追踪的基金中还有 29 只申报持有 NVAX,申报仓位最大的包括:SHAH CAPITAL MANAGEMENT (US$131.6M), Sanofi (US$74.4M), Coatue 管理 (US$36.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 NVAX 的基金

查看 NVAX 的全部基金持有人 →

常见问题

How long has Marshall Financial Group, LLC held NVAX?

Marshall Financial Group, LLC has disclosed NVAX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Marshall Financial Group, LLC's current position in NVAX?

As of Q3 2026, Marshall Financial Group, LLC holds 404.02K shares of NVAX (NOVAVAX INC), valued at $4.37M, representing 0.62% of its reported portfolio and ranking #31.

Has Marshall Financial Group, LLC been buying or selling NVAX?

In the latest 13F filing (Q3 2026), Marshall Financial Group, LLC newly opened its position in NVAX.

Which other funds hold NVAX?

Other major institutional holders of NVAX include SHAH CAPITAL MANAGEMENT, Sanofi, Coatue 管理, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.